Source: Pharmacy Times articles
Frank Qian, MD, MPH, discusses clinical considerations for omega-3 fatty acid therapy, such as the patient populations who may benefit most and important safety concerns.
Read More
by MM360 Staff | Jun 1, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Frank Qian, MD, MPH, discusses clinical considerations for omega-3 fatty acid therapy, such as the patient populations who may benefit most and important safety concerns.
Read More